In an effort to further expand our reach, Parkinson Society BC is pleased to announce a new collaboration with the Pacific Parkinson's Research Centre (PPRC). Beginning Thursday, October 3, 2019, we will be offering information and consultations to those...
To maximize the benefit of the Provincial Conference Moving Forward, Together to British Columbia's Parkinson's community, Parkinson Society British Columbia (PSBC) is offering a limited number of scholarships for people with Parkinson's (PWP) and family...
Dr. Michele Matarazzo, a neurologist at the Pacific Parkinson’s Research Centre, is using advanced Positron Emission Tomography (PET) to study dopamine loss in the brains of Parkinson’s patients. By tracking this change from early symptoms to advanced stages, he aims to better understand how Parkinson’s progresses over time.
The Summer 2019 issue of Viewpoints focuses on the mental health challenges faced by individuals with Parkinson’s disease (PD), highlighting common issues like depression, anxiety, and apathy, and the importance of addressing these alongside physical symptoms. This...
PJ and Kim Burns have a saying that they hold close: “No guilt, no shame, and no excuses.” When Kim’s husband, PJ, was diagnosed with Parkinson’s disease (PD) in 2015, at age 52, they turned to Parkinson Society BC (PSBC) for information and resources....
This September, thousands of participants across the country will gather together for Parkinson SuperWalk. This event is meant to empower the Parkinson's community and celebrate its resilience. No matter what the challenges, together we can make a difference....
Diagnosis: What the ???? I was diagnosed with Parkinson’s in 1993 at the Movement Disorders Clinic at UBC. I was 46, and had two little girls (Megan and Kathleen), a dog (Raven), and my husband (Allan). First line of defense: shoot the messenger “There was no...
If you've used Rasagiline (Azilect) or Selegline, we want your feedback. Safinamide (brand name Onstryv), which was approved in Europe in February 2015 and in the United States in March 2017, is indicated as an add-on therapy to a regimen that includes levodopa for...
Parkinson Society BC (PSBC) recently conducted a survey with the intent of better understanding the patient’s perspective in achieving symptom control with brand name (Sinemet) vs. generic forms of levodopa. The following is a summary of the 521 responses received:...
